ArticleFrontiers in immunology2026

Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia.

Joseph Kauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.